Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Organic India Introduces Organic Psyllium
Company announces avilability of new USDA certified Organic Psyllium - Whole Husk.
- Organic India Introduces Organic Psyllium
Company announces avilability of new USDA certified Organic Psyllium - Whole Husk.
- Organic India Introduces Organic Psyllium
Company announces avilability of new USDA certified Organic Psyllium - Whole Husk.
- Organic India Introduces Organic Psyllium
Company announces avilability of new USDA certified Organic Psyllium - Whole Husk.
- Organic India Introduces Organic Psyllium
Company announces avilability of new USDA certified Organic Psyllium - Whole Husk.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- LycoRed Offers Lycopene Fortification for Liquids and Pastes
Company announces the extension of its Lyc-O-Mato(R) product line for food and beverage fortification ingredients with Lyc-O-Mato(R) Red, an ideal formulation for liquid and paste applications.
- Study Shows Relationship between Lignans and Uterine Fibroids
A new study published in the American Journal of Clinical Nutrition (2006; v84, 587-93), has demonstrated a possible relationship between lignans and risk of uterine fibroids.
- Study Shows Relationship between Lignans and Uterine Fibroids
A new study published in the American Journal of Clinical Nutrition (2006; v84, 587-93), has demonstrated a possible relationship between lignans and risk of uterine fibroids.
- Study Shows Relationship between Lignans and Uterine Fibroids
A new study published in the American Journal of Clinical Nutrition (2006; v84, 587-93), has demonstrated a possible relationship between lignans and risk of uterine fibroids.
- Study Shows Relationship between Lignans and Uterine Fibroids
A new study published in the American Journal of Clinical Nutrition (2006; v84, 587-93), has demonstrated a possible relationship between lignans and risk of uterine fibroids.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- DSM Nutritional Products Announces The Launch Of New Animal-Free, Allergen-Free Form Of Redivivo® Lycopene
Company is launching a new form of redivivo® 10% CWS/S-TG that is a 10% animal-free and allergen-free lycopene.
- Tests Suggest That AlaLife(TM) Flax Lignans Possess Strong Antioxidant Activity
Company has announced the completion of research and development of high potency Flax Lignans with 40% SDG (secoisolariciresinol glucoside).
- Tests Suggest That AlaLife(TM) Flax Lignans Possess Strong Antioxidant Activity
Company has announced the completion of research and development of high potency Flax Lignans with 40% SDG (secoisolariciresinol glucoside).
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
AMES, Iowa (May 1, 2003) – Proliant Inc. introduces Iso-Chill™ Whey Protein Isolates!
Iso-Chill 9000 Whey Protein Isolate and Iso-Chill 9010 Instantized Whey Protein Isolate are processed by a proprietary, “chilling” or low temperature, novel process that provides a full balance of undenatured bioactive proteins for nutritional advantages, along with functional benefits.
Iso-Chill whey protein isolates are manufactured by a “chilling” or low temperature microfiltration process and dried by indirect heat. The low temperature microfiltration process allows the Iso-Chill whey protein isolates to provide undenatured protein with a full balance of bioactive whey protein fractions, including immunoglobulin (IgG), lactoferrin (Lf) and glycomacropeptides (GMP). Other whey processing technologies that utilize higher temperatures cause irreversible unfolding of the protein fractions that can drastically reduce the biological activity of the protein. Based on solubility at pH of 4.6, Iso-Chill has 0-3% denatured proteins, which is approximately 10% less than ion-exchange whey protein isolates and typically less than other microfiltration whey protein isolates. Iso-Chill whey protein isolates also contain up to 12 times more native GMP than ion-exchange whey protein isolates.
As well as nutritional advantages, Iso-Chill whey protein isolates have functional benefits: clean bland flavor, white-color, high solubility, high clarity, and excellent acid and heat stable properties. Over a pH range of 3.0 to 8.0, Iso-Chill is highly soluble for both acidic and neutral beverages. The clarity at neutral pH and after acidifying with either citric or phosphoric acid to pH levels of 3.0-3.5 and heated to 85°C for 20 minutes are comparable to the ion-exchange whey protein isolates.
Because of the functional benefits, Iso-Chill whey protein isolates, are ideal for acidic, heat-treated, high protein, clear RTD beverages, nutritional neutral beverages, drinkable yogurts, and instant dry-mix beverages. It is also applicable for high protein nutritional and sports bars. In combination with other Proliant whey proteins, a good-tasting, smooth-textured, nutritional bar with an extended shelf-life can be developed.
Proliant’s Dairy Ingredients Division provides specialty dairy proteins and assists customers with practical applications to a multitude of food industries worldwide. Our whey protein isolates, whey protein hydrolysates, whey protein concentrates, specialty proteins and lactose offer nutritional value attributes, diverse functional properties and flavor improvement for a variety of nutrition, dairy, bakery, confectionery, snack, savory, meat and surimi markets.
Proliant Inc. manufactures and markets protein products for the food, nutrition, human health, nutraceutical, diagnostic, life science research, biopharmaceutical and veterinary vaccine industries around the world. For more information, visit www.proliantinc.com or call 800-369-2672.
|